These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 32511285)

  • 21. Discovery of Taroxaz-104: The first potent antidote of SARS-CoV-2 VOC-202012/01 strain.
    Rabie AM
    J Mol Struct; 2021 Dec; 1246():131106. PubMed ID: 34305173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach.
    Murugan NA; Kumar S; Jeyakanthan J; Srivastava V
    Sci Rep; 2020 Nov; 10(1):19125. PubMed ID: 33154404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins.
    Elmaaty AA; Darwish KM; Khattab M; Elhady SS; Salah M; Hamed MIA; Al-Karmalawy AA; Saleh MM
    J Biomol Struct Dyn; 2022; 40(19):8866-8893. PubMed ID: 33928870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2.
    Hu S; Wang J; Zhang Y; Bai H; Wang C; Wang N; He L
    J Med Virol; 2021 May; 93(5):3143-3151. PubMed ID: 33580518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent toxic effects of Taroxaz-104 on the replication of SARS-CoV-2 particles.
    Rabie AM
    Chem Biol Interact; 2021 Jul; 343():109480. PubMed ID: 33887223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.
    Wu C; Liu Y; Yang Y; Zhang P; Zhong W; Wang Y; Wang Q; Xu Y; Li M; Li X; Zheng M; Chen L; Li H
    Acta Pharm Sin B; 2020 May; 10(5):766-788. PubMed ID: 32292689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease -
    Naik VR; Munikumar M; Ramakrishna U; Srujana M; Goudar G; Naresh P; Kumar BN; Hemalatha R
    J Biomol Struct Dyn; 2021 Aug; 39(13):4701-4714. PubMed ID: 32568620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion.
    Ho HPT; Vo DNK; Lin TY; Hung JN; Chiu YH; Tsai MH
    Biomed Pharmacother; 2022 Nov; 155():113766. PubMed ID: 36271550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.
    Wang YC; Yang WH; Yang CS; Hou MH; Tsai CL; Chou YZ; Hung MC; Chen Y
    Am J Cancer Res; 2020; 10(8):2535-2545. PubMed ID: 32905393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance.
    Deng X; StJohn SE; Osswald HL; O'Brien A; Banach BS; Sleeman K; Ghosh AK; Mesecar AD; Baker SC
    J Virol; 2014 Oct; 88(20):11886-98. PubMed ID: 25100843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2.
    Naik SR; Bharadwaj P; Dingelstad N; Kalyaanamoorthy S; Mandal SC; Ganesan A; Chattopadhyay D; Palit P
    J Biomol Struct Dyn; 2022 Sep; 40(15):6921-6938. PubMed ID: 33682632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
    Dakal TC
    Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
    Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
    J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein.
    Pillay TS
    J Clin Pathol; 2020 Jul; 73(7):366-369. PubMed ID: 32376714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors.
    Zhao J; Zhang G; Zhang Y; Yi D; Li Q; Ma L; Guo S; Li X; Guo F; Lin R; Luu G; Liu Z; Wang Y; Cen S
    Antiviral Res; 2021 Dec; 196():105209. PubMed ID: 34801588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery.
    Grum-Tokars V; Ratia K; Begaye A; Baker SC; Mesecar AD
    Virus Res; 2008 Apr; 133(1):63-73. PubMed ID: 17397958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.